temozolomide
NDC 75834-143, temozolomide, capsule, from Nivagen Pharmaceuticals, Inc..
- Product NDC
- 75834-143
- Status
- Listed
- Labeler
- Nivagen Pharmaceuticals, Inc.
- Dosage form
- CAPSULE
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA213328
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/75834-143 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- TEMOZOLOMIDE100 mg/1
Pharmacologic classes
Alkylating Activity [MoA]; Alkylating Drug [EPC]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 75834-143-05 | 75834014305 | 1 BOTTLE in 1 CARTON (75834-143-05) / 5 CAPSULE in 1 BOTTLE |
| 75834-143-14 | 75834014314 | 1 CARTON in 1 CARTON (75834-143-14) / 14 CAPSULE in 1 CARTON |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/27e5a781-e4f2-4489-9def-7971d0b86d9c
Use it
Look up 75834-143 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/75834-143 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 75834-143. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.